Correlation Between Nova Cannabis and Alibaba Health
Can any of the company-specific risk be diversified away by investing in both Nova Cannabis and Alibaba Health at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nova Cannabis and Alibaba Health into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nova Cannabis and Alibaba Health Information, you can compare the effects of market volatilities on Nova Cannabis and Alibaba Health and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nova Cannabis with a short position of Alibaba Health. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nova Cannabis and Alibaba Health.
Diversification Opportunities for Nova Cannabis and Alibaba Health
0.59 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Nova and Alibaba is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Nova Cannabis and Alibaba Health Information in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alibaba Health Infor and Nova Cannabis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nova Cannabis are associated (or correlated) with Alibaba Health. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alibaba Health Infor has no effect on the direction of Nova Cannabis i.e., Nova Cannabis and Alibaba Health go up and down completely randomly.
Pair Corralation between Nova Cannabis and Alibaba Health
Assuming the 90 days horizon Nova Cannabis is expected to under-perform the Alibaba Health. But the otc stock apears to be less risky and, when comparing its historical volatility, Nova Cannabis is 12.07 times less risky than Alibaba Health. The otc stock trades about -0.04 of its potential returns per unit of risk. The Alibaba Health Information is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 36.00 in Alibaba Health Information on September 12, 2024 and sell it today you would earn a total of 12.00 from holding Alibaba Health Information or generate 33.33% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 47.62% |
Values | Daily Returns |
Nova Cannabis vs. Alibaba Health Information
Performance |
Timeline |
Nova Cannabis |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Alibaba Health Infor |
Nova Cannabis and Alibaba Health Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Nova Cannabis and Alibaba Health
The main advantage of trading using opposite Nova Cannabis and Alibaba Health positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nova Cannabis position performs unexpectedly, Alibaba Health can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alibaba Health will offset losses from the drop in Alibaba Health's long position.Nova Cannabis vs. Leafly Holdings | Nova Cannabis vs. Leafly Holdings | Nova Cannabis vs. SunLink Health Systems | Nova Cannabis vs. Kiaro Holdings Corp |
Alibaba Health vs. China Jo Jo Drugstores | Alibaba Health vs. SunLink Health Systems | Alibaba Health vs. Leafly Holdings | Alibaba Health vs. Walgreens Boots Alliance |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |